PHATHOM PHARMACEUTICALS, INC. (PHAT) Net margin 2023–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) net profit margin by fiscal year — reported net income divided by reported revenue.
-126.3%FY2025 · since FY2023: -29558.9% → -126.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -126.3% | +478.7 pp |
| FY2024 | -605.1% | +28953.9 pp |
| FY2023 | -29558.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAT financial trends
PHAT RevenuePHAT Net incomePHAT Gross profitPHAT Gross marginPHAT Operating incomePHAT Operating marginPHAT Operating cash flowPHAT Free cash flowPHAT Capital expendituresPHAT Return on equityPHAT Stock buybacksPHAT Dividends paidPHAT Total assetsPHAT Total liabilitiesPHAT Shareholders’ equityPHAT overview →